Evidence map›Paper›PMID 30545401›Full record

ArticleMicrobiome2018

A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?

Jessica D Forbes, Chih-Yu Chen, Natalie C Knox, Ruth-Ann Marrie, Hani El-Gabalawy, Teresa de Kievit, Michelle Alfa, Charles N Bernstein, Gary Van Domselaar

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04342507 (Effects of Probiotic Oral Supplementation on the Treatment of Chalazion in Adults), which is not on this map. Cited by 253 papers, 20 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
253citing papers in PubMed, 20 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04342507 nacompletednot on this mapstarted 2019, after this paper: background citation

Effects of Probiotic Oral Supplementation on the Treatment of Chalazion in Adults: a Pilot Study on 20 Patients

TypeinterventionalSponsorUniversity of MoliseRan2019 to 2020Enrolled20ConditionsChalazionArmsconservative treatment, probiotics
3 · Its place in the literature

Who cites it

253 citing papers in PubMed, 20 syntheses or guidelines pooled it, 461 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

193 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jessica D ForbesDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Chih-Yu ChenNational Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada.
Natalie C KnoxNational Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada.
Ruth-Ann MarrieDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Hani El-GabalawyDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Teresa de KievitDepartment of Microbiology, University of Manitoba, Winnipeg, MB, Canada.
Michelle AlfaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
Charles N BernsteinDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Gary Van DomselaarUniversity of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada. Gary.vandomselaar@canada.ca.
University of Manitoba · CAPublic Health Agency of Canada · CAArthritis Research Centre of Canada · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable knowledge has emerged regarding the plausible role of the gut microbiome in IMIDs. This study used 16S rRNA gene amplicon sequencing to compare the gut microbiota of patients with Crohn's disease (CD; N = 20), ulcerative colitis (UC; N = 19), multiple sclerosis (MS; N = 19), and rheumatoid arthritis (RA; N = 21) versus healthy controls (HC; N = 23). Biological replicates were collected from participants within a 2-month interval. This study aimed to identify common (or unique) taxonomic biomarkers of IMIDs using both differential abundance testing and a machine learning approach.

resultsSignificant microbial community differences between cohorts were observed (pseudo F = 4.56; p = 0.01). Richness and diversity were significantly different between cohorts (pFDR < 0.001) and were lowest in CD while highest in HC. Abundances of Actinomyces, Eggerthella, Clostridium III, Faecalicoccus, and Streptococcus (pFDR < 0.001) were significantly higher in all disease cohorts relative to HC, whereas significantly lower abundances were observed for Gemmiger, Lachnospira, and Sporobacter (pFDR < 0.001). Several taxa were found to be differentially abundant in IMIDs versus HC including significantly higher abundances of Intestinibacter in CD, Bifidobacterium in UC, and unclassified Erysipelotrichaceae in MS and significantly lower abundances of Coprococcus in CD, Dialister in MS, and Roseburia in RA. A machine learning approach to classify disease versus HC was highest for CD (AUC = 0.93 and AUC = 0.95 for OTU and genus features, respectively) followed by MS, RA, and UC. Gemmiger and Faecalicoccus were identified as important features for classification of subjects to CD and HC. In general, features identified by differential abundance testing were consistent with machine learning feature importance.

conclusionsThis study identified several gut microbial taxa with differential abundance patterns common to IMIDs. We also found differentially abundant taxa between IMIDs. These taxa may serve as biomarkers for the detection and diagnosis of IMIDs and suggest there may be a common component to IMID etiology.

Indexed as

AdultArthritis, RheumatoidBacteriaCase-Control StudiesColitis, UlcerativeCrohn DiseaseDNA, BacterialDNA, RibosomalDysbiosisFemaleGastrointestinal MicrobiomeHumansInflammatory Bowel DiseasesMachine LearningMaleMetagenomicsDNA, BacterialDNA, RibosomalRNA, Ribosomal, 16S16S rRNA gene amplicon sequencingBacteriaGut microbiotaImmune-mediated inflammatory diseaseInflammatory bowel diseaseMachine learning classifiersMultiple sclerosisRheumatoid arthritisTaxonomic biomarkers

Identifiers

PMID30545401
PMCPMC6292067
OpenAlexW2904925223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.